Biolinq
San Diego, California, United States · Biotechnology, Health Care, Medical Device · 107 employees
Biolinq is a healthcare technology company pioneering precision multi-analyte wearable sensors to improve metabolic health. The company’s biosensor platform is designed to inform and inspire with unparalleled simplicity to support healthier living. With microsensors that reside just below the skin's surface, Biolinq is redefining the future of continuous small molecule biosensing.
Funding history
- Series C — $100.0M — Apr 2025
- Venture - Series Unknown — $90.0M — Mar 2025
- Venture - Series Unknown — $59.1M — Sep 2024
- Funding Round — $58.0M — Apr 2024
- Venture - Series Unknown — $53.7M — Mar 2024
Recent signals
- Apr 22, 2025: Raised $100.0M in Series C
- Mar 21, 2025: Raised $90.0M in Venture - Series Unknown
- Sep 13, 2024: Raised $59.1M in Venture - Series Unknown
- Apr 04, 2024: Raised $58.0M in Funding Round
- Mar 26, 2024: Raised $53.7M in Venture - Series Unknown
- Dec 26, 2023: Raised $35.1M in Venture - Series Unknown
- Jun 01, 2022: Raised $77.9M in Venture - Series Unknown
- Sep 17, 2021: Raised $62.2M in Venture - Series Unknown
See plans & pricing → Track Biolinq’s funding, hiring, and signals — with verified contacts — on Fundz.